scholarly article | Q13442814 |
P50 | author | Natalie Medlicott | Q72300342 |
James Ussher | Q63433856 | ||
P2093 | author name string | Andrew M Robinson | |
P2860 | cites work | Inpatient care for septicemia or sepsis: a challenge for patients and hospitals | Q64126923 |
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock | Q83177700 | ||
Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics | Q24623358 | ||
Updated functional classification of beta-lactamases | Q24644798 | ||
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 | ||
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome | Q33803393 | ||
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. | Q33973352 | ||
Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q34254372 | ||
A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry, microarray and PCR. | Q34424853 | ||
Modern clinical microbiology: new challenges and solutions | Q34982856 | ||
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures | Q35084748 | ||
Detection of carbapenemase activity directly from blood culture vials using MALDI-TOF MS: a quick answer for the right decision | Q35145706 | ||
Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints | Q35192249 | ||
Clinical Performance of a Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method for Detection of Certain blaKPC-Containing Plasmids | Q35764330 | ||
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! | Q36242554 | ||
Resistance in gram-negative bacteria: enterobacteriaceae | Q36492668 | ||
Defining an extended-spectrum beta-lactamase | Q37043580 | ||
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
AmpC beta-lactamases | Q37366249 | ||
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock | Q37563005 | ||
Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand | Q38220245 | ||
Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases | Q38857234 | ||
Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology | Q40470351 | ||
Preparation of positive blood cultures for direct MALDI-ToF MS identification. | Q40650645 | ||
Rapid detection of cefotaxime-resistant Escherichia coli by LC-MS. | Q41002849 | ||
Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry | Q41890312 | ||
Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae | Q43195304 | ||
Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS. | Q43971402 | ||
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints | Q46920641 | ||
The clinical and public health challenge of Gram-negative resistance in Australasia. | Q51330567 | ||
Sepsis in European intensive care units: results of the SOAP study. | Q54471944 | ||
Diagnostic techniques in bloodstream infections: where are we going? | Q60169805 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Enterobacteriaceae | Q380136 |
P304 | page(s) | FSO142 | |
P577 | publication date | 2016-09-09 | |
P1433 | published in | Future science OA | Q27726739 |
P1476 | title | The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC | |
P478 | volume | 2 |
Q90458611 | Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae | cites work | P2860 |
Search more.